| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $124.3M | — | +11.9% |
| Cost of Revenue | $40.9M | — | +20.5% |
| Gross Profit | $83.4M | — | +8.1% |
| R&D Expense | $24.7M | — | +1.0% |
| SG&A Expense | $37.4M | — | -7.9% |
| Operating Income | -$14.47B | — | -144.4% |
| Pre-tax Income | -$14.47B | — | -143.4% |
| Income Tax | -$1.92B | — | -11.5% |
| Net Income | -$12.54B | — | -197.4% |
| EPS (Basic) | -$38.25 | — | -132.0% |
| EPS (Diluted) | -$38.25 | — | -132.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.21B | -4.1% | +3560.5% |
| Accounts Receivable | $122.3M | -40.6% | +16.9% |
| Current Assets | $2.39B | -6.7% | +1074.4% |
| Total Assets | $54.27B | -12.0% | +23.6% |
| Current Liabilities | $395.1M | -13.5% | +28.0% |
| Long-term Debt | $8.20B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $14.0M | — | +685.6% |
| Capital Expenditures | $952K | — | -65.2% |
| Investing Cash Flow | -$7.25B | — | +5.5% |
| Financing Cash Flow | $7.15B | — | -7.1% |
| Free Cash Flow | $13.0M | — | +354.3% |
| +0.7% |
| Total Liabilities | $8.63B | -18.5% | -16.9% |
| Stockholders' Equity | $36.65B | -16.9% | +13.7% |